{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:22:40Z","timestamp":1794028960499,"version":"4.8.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171678"],"award-info":[{"award-number":["82171678"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20200109140614667"],"award-info":[{"award-number":["JCYJ20200109140614667"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Programe","award":["JCYJ20230807143504009"],"award-info":[{"award-number":["JCYJ20230807143504009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The placenta plays a crucial role in maintaining normal pregnancy. The failure of spiral artery remodeling (SAR) is a key factor leading to placental ischemia and poor perfusion which is strongly associated with obstetric diseases, including preeclampsia (PE) and fetal growth restriction (FGR). Existing interventions for PE and FGR are limited and termination of pregnancy is inevitable when the maternal or fetus condition deteriorates. Considering the safety of the mother and fetus, treatments that may penetrate the placental barrier and harm the fetus are not accepted. Developing targeted treatment strategies for these conditions is urgent and necessary. With the proven efficacy of targeted therapy in treating conditions such as endometrial cancer and trophoblastic tumors, research on placental dysfunction continues to deepen. This article reviews the studies on placenta-targeted treatment and drug delivery strategies, summarizes the characteristics proposes corresponding improvement measures in targeted treatment, provides solutions for existing problems, and makes suggestions for future studies.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s12015-024-10739-x","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:45:49Z","timestamp":1717062349000},"page":"1501-1511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Placenta-targeted Treatment Strategies for Preeclampsia and Fetal Growth Restriction: An Opportunity and Major Challenge"],"prefix":"10.1007","volume":"20","author":[{"given":"Jianjian","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya\u2019nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7049-6193","authenticated-orcid":false,"given":"Yin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"10739_CR1","first-page":"139","volume":"176","author":"M Rashighi","year":"2017","unstructured":"Rashighi, M., & Harris, J. E. (2017). Placental control of drug delivery. Advanced Drug Delivery Reviews, 176, 139\u2013148.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10739_CR2","doi-asserted-by":"crossref","unstructured":"Saghian, R., Bogle, G., James, J. L. (2019). Establishment of maternal blood supply to the placenta: Insights into plugging, unplugging and trophoblast behaviour from an agent-based model. Interface Focus ;9.","DOI":"10.1098\/rsfs.2019.0019"},{"key":"10739_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","volume":"204","author":"I Brosens","year":"2011","unstructured":"Brosens, I., Pijnenborg, R., Vercruysse, L., et al. (2011). The great obstetrical syndromes are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology, 204, 193\u2013201.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10739_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10060953","volume":"10","author":"MK Jena","year":"2020","unstructured":"Jena, M. K., Sharma, N. R., Petitt, M., et al. (2020). Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules, 10, 1\u201328.","journal-title":"Biomolecules"},{"key":"10739_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","volume":"15","author":"EA Phipps","year":"2019","unstructured":"Phipps, E. A., Thadhani, R., Benzing, T., et al. (2019). Pre-eclampsia: Pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology, 15, 275\u2013289.","journal-title":"Nature Reviews Nephrology"},{"key":"10739_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard, S. E., Min, J-Y., Merchan, J., et al. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest, 111, 649\u2013658.","journal-title":"J Clin Invest"},{"key":"10739_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1089\/scd.2021.0174","volume":"1","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Shi, H., Wu, D., et al. (2021). The Protective Benefit of Heme Oxygenase-1 gene-modified human placenta-derived mesenchymal stem cells in a N-Nitro-L-Arginine Methyl Ester-Induced Preeclampsia-Like Rat Model: Possible implications for placental angiogenesis. Stem Cells and Development, 1, 991\u20131002.","journal-title":"Stem Cells and Development"},{"key":"10739_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1471-0528.2003.02014.x","volume":"110","author":"TGS Group","year":"2003","unstructured":"Group, T. G. S. (2003). A randomised trial of timed delivery for the compromised preterm fetus: Short term outcomes and bayesian interpretation. BJOG An Int J Obstet Gynaecol, 110, 27\u201332.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10739_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/mrd.23644","volume":"89","author":"RL Wilson","year":"2022","unstructured":"Wilson, R. L., Lampe, K., Gupta, M. K., et al. (2022). Nanoparticle-mediated transgene expression of insulin-like growth factor 1 in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrations. Molecular Reproduction and Development, 89, 540\u2013553.","journal-title":"Molecular Reproduction and Development"},{"key":"10739_CR10","first-page":"1","volume":"20","author":"B Zhang","year":"2019","unstructured":"Zhang, B., Liang, R., Zheng, M., et al. (2019). Surface-functionalized nanoparticles as efficient tools in targeted therapy of pregnancy complications. International Journal of Molecular Sciences, 20, 1\u201316.","journal-title":"International Journal of Molecular Sciences"},{"key":"10739_CR11","first-page":"1052","volume":"234","author":"MK Jena","year":"2018","unstructured":"Jena, M. K., Sharma, N. R., Petitt, M., et al. (2018). Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Jounal Cell Physiol, 234, 1052\u20131061.","journal-title":"Jounal Cell Physiol"},{"key":"10739_CR12","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1530\/JOE-17-0185","volume":"234","author":"CP Sibley","year":"2017","unstructured":"Sibley, C. P. (2017). Treating the dysfunctional placenta. Journal of Endocrinology, 234, R81\u2013R97.","journal-title":"Journal of Endocrinology"},{"key":"10739_CR13","doi-asserted-by":"publisher","first-page":"113950","DOI":"10.1016\/j.addr.2021.113950","volume":"177","author":"A Sharma","year":"2021","unstructured":"Sharma, A., Sah, N., Kannan, S., et al. (2021). Targeted drug delivery for maternal and perinatal health: Challenges and opportunities. Advanced Drug Delivery Reviews, 177, 113950.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10739_CR14","doi-asserted-by":"publisher","first-page":"104836","DOI":"10.1016\/j.phrs.2020.104836","volume":"157","author":"E Ganguly","year":"2020","unstructured":"Ganguly, E., Hula, N., Spaans, F., et al. (2020). Placenta-targeted treatment strategies: An opportunity to impact fetal development and improve offspring health later in life. Pharmacological Research, 157, 104836.","journal-title":"Pharmacological Research"},{"key":"10739_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/uog.19186","volume":"52","author":"KM Groom","year":"2018","unstructured":"Groom, K. M., Ganzevoort, W., Alfirevic, Z., et al. (2018). Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): Comment from the STRIDER Consortium. Ultrasound in Obstetrics and Gynecology, 52, 295\u2013296.","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"key":"10739_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8, 726\u2013736.","journal-title":"Nature Reviews Immunology"},{"key":"10739_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum, J. A., Ong, J. F., & Karp, J. M. (2014). Mesenchymal stem cells: Immune evasive, not immune privileged. Nature Biotechnology, 32, 252\u2013260.","journal-title":"Nature Biotechnology"},{"key":"10739_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.biochi.2013.06.020","volume":"95","author":"D Drago","year":"2013","unstructured":"Drago, D., Cossetti, C., Iraci, N., et al. (2013). The stem cell secretome and its role in brain repair. Biochimie, 95, 2271\u20132285.","journal-title":"Biochimie"},{"key":"10739_CR19","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","volume":"76","author":"A Naji","year":"2019","unstructured":"Naji, A., Eitoku, M., Favier, B., et al. (2019). Biological functions of mesenchymal stem cells and clinical implications. Cellular and Molecular Life Sciences, 76, 3323\u20133348.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10739_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-019-2268-9","volume":"19","author":"S Grimes","year":"2019","unstructured":"Grimes, S., Bombay, K., Lanes, A., et al. (2019). Potential biological therapies for severe preeclampsia: A systematic review and meta-analysis. Bmc Pregnancy and Childbirth, 19, 1\u201312.","journal-title":"Bmc Pregnancy and Childbirth"},{"key":"10739_CR21","first-page":"1","volume":"9","author":"L Liu","year":"2014","unstructured":"Liu, L., Zhao, G., Fan, H., et al. (2014). Mesenchymal stem cells ameliorate Th1-induced pre-eclampsia-like symptoms in mice via the suppression of TNF-\u03b1 expression. PLoS One, 9, 1\u201310.","journal-title":"PLoS One"},{"key":"10739_CR22","first-page":"S57","volume":"28","author":"N Charif","year":"2017","unstructured":"Charif, N., Li, Y. Y., Targa, L., et al. (2017). Aging of bone marrow mesenchymal stromal\/stem cells: Implications on autologous regenerative medicine. Biomedical Materials and Engineering, 28, S57\u2013S63.","journal-title":"Biomedical Materials and Engineering"},{"key":"10739_CR23","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3892\/etm.2015.2742","volume":"10","author":"L Fu","year":"2015","unstructured":"Fu, L., Liu, Y., Zhang, D., et al. (2015). Beneficial effect of human umbilical cord\u2013derived mesenchymal stem cells on an endotoxin\u2013induced rat model of preeclampsia. Exp Ther Med, 10, 1851\u20131856.","journal-title":"Exp Ther Med"},{"key":"10739_CR24","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1177\/1933719116630417","volume":"23","author":"LL Wang","year":"2016","unstructured":"Wang, L. L., Yu, Y., Guan, H. B., et al. (2016). Effect of human umbilical cord mesenchymal stem cell transplantation in a rat model of Preeclampsia. Reprod Sci, 23, 1058\u20131070.","journal-title":"Reprod Sci"},{"key":"10739_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9051145","volume":"9","author":"VK Mishra","year":"2020","unstructured":"Mishra, V. K., Shih, H. H., Parveen, F., et al. (2020). Identifying the therapeutic significance of mesenchymal stem cells. Cells, 9, 1\u201330.","journal-title":"Cells"},{"key":"10739_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.placenta.2020.07.007","volume":"99","author":"D Wu","year":"2020","unstructured":"Wu, D., Liu, Y., Liu, X. X., et al. (2020). Heme oxygenase-1 gene modified human placental mesenchymal stem cells promote placental angiogenesis and spiral artery remodeling by improving the balance of angiogenic factors in vitro. Placenta, 99, 70\u201377.","journal-title":"Placenta"},{"key":"10739_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1158\/0008-5472.CAN-08-3562","volume":"69","author":"PJ Mishra","year":"2009","unstructured":"Mishra, P. J., Mishra, P. J., Glod, J. W., et al. (2009). Mesenchymal stem cells: Flip side of the coin. Cancer Research, 69, 1255\u20131258.","journal-title":"Cancer Research"},{"key":"10739_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau, J., & Sens\u00e9b\u00e9, L. (2018). Mesenchymal stromal cells: Clinical challenges and Therapeutic opportunities. Cell Stem Cell, 22, 824\u2013833.","journal-title":"Cell Stem Cell"},{"key":"10739_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer, E., Benseler, V., Kroemer, A., et al. (2012). Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Frontiers in Immunology, 3, 1\u20139.","journal-title":"Frontiers in Immunology"},{"key":"10739_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.biotechadv.2018.03.011","volume":"36","author":"L Bacakova","year":"2018","unstructured":"Bacakova, L., Zarubova, J., Travnickova, M., et al. (2018). Stem cells: Their source, potency and use in regenerative therapies with focus on adipose-derived stem cells \u2013 a review. Biotechnology Advances, 36, 1111\u20131126.","journal-title":"Biotechnology Advances"},{"key":"10739_CR31","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2106\/00004623-200407000-00029","volume":"86","author":"GF Muschler","year":"2004","unstructured":"Muschler, G. F., Nakamoto, C., & Griffith, L. G. (2004). Engineering principles of clinical cell-based tissue engineering. J Bone Jt Surg, 86, 1541\u20131558.","journal-title":"J Bone Jt Surg"},{"key":"10739_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/sctm.19-0202","volume":"9","author":"M Kabat","year":"2020","unstructured":"Kabat, M., Bobkov, I., Kumar, S., et al. (2020). Trends in mesenchymal stem cell clinical trials 2004\u20132018: Is efficacy optimal in a narrow dose range? Stem Cells Transl Med, 9, 17\u201327.","journal-title":"Stem Cells Transl Med"},{"key":"10739_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10091320","volume":"10","author":"R Guy","year":"2020","unstructured":"Guy, R., & Offen, D. (2020). Promising opportunities for treating neurodegenerative diseases with mesenchymal stem cell-derived exosomes. Biomolecules, 10, 1\u201322.","journal-title":"Biomolecules"},{"key":"10739_CR34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/aji.12311","volume":"72","author":"L Mincheva-Nilsson","year":"2014","unstructured":"Mincheva-Nilsson, L., & Baranov, V. (2014). Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in Human Reproduction: Immune Modulation for pregnancy success. American Journal of Reproductive Immunology, 72, 440\u2013457.","journal-title":"American Journal of Reproductive Immunology"},{"key":"10739_CR35","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.ajog.2015.07.001","volume":"213","author":"MD Mitchell","year":"2015","unstructured":"Mitchell, M. D., Peiris, H. N., Kobayashi, M., et al. (2015). Placental exosomes in normal and complicated pregnancy. American Journal of Obstetrics and Gynecology, 213, S173\u2013S181.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10739_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.placenta.2018.02.006","volume":"64","author":"J Miranda","year":"2018","unstructured":"Miranda, J., Paules, C., Nair, S., et al. (2018). Placental exosomes profile in maternal and fetal circulation in intrauterine growth restriction - liquid biopsies to monitoring fetal growth. Placenta, 64, 34\u201343.","journal-title":"Placenta"},{"key":"10739_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ymthe.2020.09.026","volume":"29","author":"X Zou","year":"2021","unstructured":"Zou, X., Yuan, M., Zhang, T., et al. (2021). EVs containing host restriction factor IFITM3 inhibited ZIKV infection of fetuses in pregnant mice through trans-placenta delivery. Molecular Therapy, 29, 176\u2013190.","journal-title":"Molecular Therapy"},{"key":"10739_CR38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s12015-022-10337-9","volume":"18","author":"G Camussi","year":"2022","unstructured":"Camussi, G. (2022). Exosomes and microvesicles: From Stem Cell Biology to Translation in Human diseases. Stem Cell Rev Reports, 18, 853.","journal-title":"Stem Cell Rev Reports"},{"key":"10739_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-019-0150-2","volume":"16","author":"GH Cui","year":"2019","unstructured":"Cui, G. H., Guo, H. D., Li, H., et al. (2019). RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer\u2019s disease. Immun Ageing, 16, 1\u201312.","journal-title":"Immun Ageing"},{"key":"10739_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-022-01636-x","volume":"20","author":"Y Lin","year":"2022","unstructured":"Lin, Y., Yan, M., Bai, Z., et al. (2022). Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy. J Nanobiotechnology, 20, 1\u201322.","journal-title":"J Nanobiotechnology"},{"key":"10739_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02629-7","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun, Y., Liu, G., Zhang, K., et al. (2021). Mesenchymal stem cells-derived exosomes for drug delivery. Stem Cell Research & Therapy, 12, 1\u201315.","journal-title":"Stem Cell Research & Therapy"},{"key":"10739_CR42","doi-asserted-by":"crossref","unstructured":"Wang, M., Yuan, Q., & Xie, L. (2018). Mesenchymal stem cell-based immunomodulation: Properties and clinical application. Stem Cells Int. ;2018.","DOI":"10.1155\/2018\/3057624"},{"key":"10739_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0068451","volume":"8","author":"C Salomon","year":"2013","unstructured":"Salomon, C., Ryan, J., Sobrevia, L., et al. (2013). Exosomal Signaling during Hypoxia mediates microvascular endothelial cell Migration and Vasculogenesis. PLoS One, 8, 1\u201324.","journal-title":"PLoS One"},{"key":"10739_CR44","first-page":"1","volume":"19","author":"Z Cao","year":"2023","unstructured":"Cao, Z., Li, P., Li, Y., et al. (2023). Encapsulation of Nano-Bortezomib in apoptotic stem cell-derived vesicles for the treatment of multiple myeloma. Small (Weinheim An Der Bergstrasse, Germany), 19, 1\u201312.","journal-title":"Small (Weinheim An Der Bergstrasse, Germany)"},{"key":"10739_CR45","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/cmi.2014.42","volume":"11","author":"D Tannetta","year":"2014","unstructured":"Tannetta, D., Dragovic, R., Alyahyaei, Z., et al. (2014). Extracellular vesicles and reproduction-promotion of successful pregnancy. Cellular & Molecular Immunology, 11, 548\u2013563.","journal-title":"Cellular & Molecular Immunology"},{"key":"10739_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-022-00853-z","volume":"20","author":"M Ghafourian","year":"2022","unstructured":"Ghafourian, M., Mahdavi, R., Akbari Jonoush, Z., et al. (2022). The implications of exosomes in pregnancy: Emerging as new diagnostic markers and therapeutics targets. Cell Commun Signal, 20, 1\u201319.","journal-title":"Cell Commun Signal"},{"key":"10739_CR47","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.biopha.2018.06.032","volume":"105","author":"ZH Xiong","year":"2018","unstructured":"Xiong, Z. H., Wei, J., Lu, M. Q., et al. (2018). Protective effect of human umbilical cord mesenchymal stem cell exosomes on preserving the morphology and angiogenesis of placenta in rats with preeclampsia. Biomedicine & Pharmacotherapy, 105, 1240\u20131247.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10739_CR48","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1021\/bc500291r","volume":"25","author":"T Smyth","year":"2014","unstructured":"Smyth, T., Petrova, K., Payton, N. M., et al. (2014). Surface functionalization of exosomes using click chemistry. Bioconjugate Chemistry, 25, 1777\u20131784.","journal-title":"Bioconjugate Chemistry"},{"key":"10739_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","volume":"219","author":"EV Batrakova","year":"2015","unstructured":"Batrakova, E. V., & Kim, M. S. (2015). Using exosomes, naturally-equipped nanocarriers, for drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society, 219, 396\u2013405.","journal-title":"Journal of Controlled Release : Official Journal of the Controlled Release Society"},{"key":"10739_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbcan.2014.04.005","volume":"1846","author":"KB Johnsen","year":"2014","unstructured":"Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., et al. (2014). A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta - Rev Cancer, 1846, 75\u201387.","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"key":"10739_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","volume":"172","author":"SAA Kooijmans","year":"2013","unstructured":"Kooijmans, S. A. A., Stremersch, S., Braeckmans, K., et al. (2013). Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. Journal of Controlled Release : Official Journal of the Controlled Release Society, 172, 229\u2013238.","journal-title":"Journal of Controlled Release : Official Journal of the Controlled Release Society"},{"key":"10739_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-022-01660-x","volume":"20","author":"KS Park","year":"2022","unstructured":"Park, K. S., Bergqvist, M., L\u00e4sser, C., et al. (2022). Targeting Myd88 using peptide-loaded mesenchymal stem cell membrane-derived synthetic vesicles to treat systemic inflammation. J Nanobiotechnology, 20, 1\u201315.","journal-title":"J Nanobiotechnology"},{"key":"10739_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.actbio.2022.11.057","volume":"157","author":"N Hu","year":"2023","unstructured":"Hu, N., Cai, Z., Jiang, X., et al. (2023). Hypoxia-pretreated ADSC-derived exosome-embedded hydrogels promote angiogenesis and accelerate diabetic wound healing. Acta Biomaterialia, 157, 175\u2013186.","journal-title":"Acta Biomaterialia"},{"key":"10739_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-9-47","volume":"9","author":"TS Chen","year":"2011","unstructured":"Chen, T. S., Arslan, F., Yin, Y., et al. (2011). Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med, 9, 1\u201310.","journal-title":"J Transl Med"},{"key":"10739_CR55","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315\u2013317.","journal-title":"Cytotherapy"},{"key":"10739_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02613-1","volume":"13","author":"M Li","year":"2022","unstructured":"Li, M., Jiang, Y., Hou, Q., et al. (2022). Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: Current status and future prospects. Stem Cell Research & Therapy, 13, 1\u201321.","journal-title":"Stem Cell Research & Therapy"},{"key":"10739_CR57","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/wnan.53","volume":"1","author":"M Saunders","year":"2009","unstructured":"Saunders, M. (2009). Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomedicine Nanobiotechnology, 1, 671\u2013684.","journal-title":"Wiley Interdiscip Rev Nanomedicine Nanobiotechnology"},{"key":"10739_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep00847","volume":"2","author":"H Yang","year":"2012","unstructured":"Yang, H., Sun, C., Fan, Z., et al. (2012). Effects of gestational age and surface modification on materno-fetal transfer of nanoparticles in murine pregnancy. Scientific Reports, 2, 1\u20138.","journal-title":"Scientific Reports"},{"key":"10739_CR59","first-page":"1","volume":"10","author":"NA Ellah","year":"2015","unstructured":"Ellah, N. A., Taylor, L., Troja, W., et al. (2015). Development of non-viral, trophoblast-specific gene delivery for placental therapy. PLoS One, 10, 1\u201313.","journal-title":"PLoS One"},{"key":"10739_CR60","first-page":"1","volume":"2018","author":"B Zhang","year":"2018","unstructured":"Zhang, B., Chen, Z., Han, J., et al. (2018). Comprehensive evaluation of the effectiveness and safety of placenta-targeted drug delivery using three complementary methods. Journal of Visualized Experiments : Jove, 2018, 1\u201311.","journal-title":"Journal of Visualized Experiments : Jove"},{"key":"10739_CR61","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.7150\/thno.22904","volume":"8","author":"B Zhang","year":"2018","unstructured":"Zhang, B., Tan, L., Yu, Y., et al. (2018). Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice. Theranostics, 8, 2765\u20132781.","journal-title":"Theranostics"},{"key":"10739_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2020.02.006","volume":"93","author":"RL Wilson","year":"2020","unstructured":"Wilson, R. L., Owens, K., Sumser, E. K., et al. (2020). Nanoparticle mediated increased insulin-like growth factor 1 expression enhances human placenta syncytium function. Placenta, 93, 1\u20137.","journal-title":"Placenta"},{"key":"10739_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03128-7","volume":"7","author":"D Ho","year":"2017","unstructured":"Ho, D., Leong, J. W., Crew, R. C., et al. (2017). Maternal-placental-fetal biodistribution of multimodal polymeric nanoparticles in a pregnant rat model in mid and late gestation. Scientific Reports, 7, 1\u201311.","journal-title":"Scientific Reports"},{"key":"10739_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2020.00001","volume":"8","author":"L Li","year":"2020","unstructured":"Li, L., Yang, H., Chen, P., et al. (2020). Trophoblast-targeted Nanomedicine modulates placental sFLT1 for Preeclampsia Treatment. Frontiers in Bioengineering and Biotechnology, 8, 1\u201310.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"10739_CR65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s13346-016-0281-3","volume":"6","author":"S Tonello","year":"2016","unstructured":"Tonello, S., Moore, M. C., Sharma, B., et al. (2016). Controlled release of a heterogeneous human placental matrix from PLGA microparticles to modulate angiogenesis. Drug Deliv Transl Res, 6, 174\u2013183.","journal-title":"Drug Deliv Transl Res"},{"key":"10739_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.placenta.2019.02.002","volume":"84","author":"CA Whigham","year":"2019","unstructured":"Whigham, C. A., MacDonald, T. M., Walker, S. P., et al. (2019). The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development. Placenta, 84, 28\u201331.","journal-title":"Placenta"},{"key":"10739_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.1600349","volume":"2","author":"A King","year":"2016","unstructured":"King, A., Ndifon, C., Lui, S., et al. (2016). Tumor-homing peptides as tools for targeted delivery of payloads to the placenta. Science Advances, 2, 1\u201316.","journal-title":"Science Advances"},{"key":"10739_CR68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.addr.2016.05.009","volume":"110\u2013111","author":"R Liu","year":"2017","unstructured":"Liu, R., Li, X., Xiao, W., et al. (2017). Tumor-targeting peptides from combinatorial libraries. Advanced Drug Delivery Reviews, 110\u2013111, 13\u201337.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10739_CR69","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/humupd\/dml048","volume":"13","author":"C Ferretti","year":"2007","unstructured":"Ferretti, C., Bruni, L., Dangles-Marie, V., et al. (2007). Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Human Reproduction Update, 13, 121\u2013141.","journal-title":"Human Reproduction Update"},{"key":"10739_CR70","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3109\/1061186X.2014.950666","volume":"22","author":"EM George","year":"2014","unstructured":"George, E. M., Liu, H., Robinson, G. G., et al. (2014). A polypeptide drug carrier for maternal delivery and prevention of fetal exposure. Journal of Drug Targeting, 22, 935\u2013947.","journal-title":"Journal of Drug Targeting"},{"key":"10739_CR71","doi-asserted-by":"crossref","unstructured":"Logue, O. C., Mahdi, F., Chapman, H. (2017). A maternally sequestered, biopolymer-stabilized vascular endothelial growth factor (VEGF) chimera for treatment of preeclampsia. J Am Heart Assoc ;6.","DOI":"10.1161\/JAHA.117.007216"},{"key":"10739_CR72","doi-asserted-by":"crossref","unstructured":"Li, Q., Liu, X., Liu, W. Placenta-targeted nanoparticles loaded with PFKFB3 overexpression plasmids enhance angiogenesis and placental function. Bioengineering 2022;9.","DOI":"10.3390\/bioengineering9110652"},{"key":"10739_CR73","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.7150\/thno.19678","volume":"7","author":"N Cureton","year":"2017","unstructured":"Cureton, N., Korotkova, I., Baker, B., et al. (2017). Selective targeting of a novel vasodilator to the uterine vasculature to treat impaired uteroplacental perfusion in pregnancy. Theranostics, 7, 3715\u20133731.","journal-title":"Theranostics"},{"key":"10739_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2017.07.360","volume":"58","author":"J Yu","year":"2017","unstructured":"Yu, J., Jia, J., Guo, X., et al. (2017). Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery. Placenta, 58, 1\u20138.","journal-title":"Placenta"},{"key":"10739_CR75","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/10641955.2015.1122034","volume":"35","author":"VC Sandrim","year":"2016","unstructured":"Sandrim, V. C., Eleuterio, N., Pilan, E., et al. (2016). Plasma levels of increased mir-195-5p correlates with the sFLT-1 levels in preeclampsia. Hypertension in Pregnancy, 35, 150\u2013158.","journal-title":"Hypertension in Pregnancy"},{"key":"10739_CR76","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nbt.4297","volume":"36","author":"AA Turanov","year":"2018","unstructured":"Turanov, A. A., Lo, A., Hassler, M. R., et al. (2018). RNAi modulation of placental sFLT1 for the treatment of preeclampsia. Nature Biotechnology, 36, 1164\u20131173.","journal-title":"Nature Biotechnology"},{"key":"10739_CR77","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1089\/hum.2014.065","volume":"26","author":"SG Keswani","year":"2015","unstructured":"Keswani, S. G., Balaji, S., Katz, A. B., et al. (2015). Intraplacental Gene Therapy with Ad-IGF-1 corrects naturally occurring rabbit model of Intrauterine Growth Restriction. Human Gene Therapy, 26, 172\u2013182.","journal-title":"Human Gene Therapy"},{"key":"10739_CR78","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.placenta.2013.11.012","volume":"35","author":"H Jones","year":"2014","unstructured":"Jones, H., Crombleholme, T., & Habli, M. (2014). Regulation of amino acid transporters by adenoviral-mediated human insulin-like growth factor-1 in a mouse model of placental insufficiency in vivo and the human trophoblast line BeWo in vitro. Placenta, 35, 132\u2013138.","journal-title":"Placenta"},{"key":"10739_CR79","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/pr.2017.18","volume":"81","author":"T Alsaied","year":"2017","unstructured":"Alsaied, T., Omar, K., James, J. F., et al. (2017). Fetal origins of adult cardiac disease: A novel approach to prevent fetal growth restriction induced cardiac dysfunction using insulin like growth factor. Pediatric Research, 81, 919\u2013925.","journal-title":"Pediatric Research"},{"key":"10739_CR80","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/hum.2013.214","volume":"25","author":"DJ Carr","year":"2014","unstructured":"Carr, D. J., Wallace, J. M., Aitken, R. P., et al. (2014). Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies. Human Gene Therapy, 25, 375\u2013384.","journal-title":"Human Gene Therapy"},{"key":"10739_CR81","doi-asserted-by":"publisher","first-page":"R344","DOI":"10.1152\/ajpregu.00210.2017","volume":"315","author":"OR Vaughan","year":"2018","unstructured":"Vaughan, O. R., Rossi, C. A., Ginsberg, Y., et al. (2018). Perinatal and long-term effects of maternal uterine artery adenoviral VEGF-A165 gene therapy in the growth-restricted guinea pig fetus. Am J Physiol - Regul Integr Comp Physiol, 315, R344\u2013R353.","journal-title":"Am J Physiol - Regul Integr Comp Physiol"},{"key":"10739_CR82","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1210\/en.2019-00059","volume":"160","author":"JS Babischkin","year":"2019","unstructured":"Babischkin, J. S., Aberdeen, G. W., Lindner, J. R., et al. (2019). Vascular endothelial growth factor delivery to placental basal plate promotes uterine artery remodeling in the primate. Endocrinology, 160, 1492\u20131505.","journal-title":"Endocrinology"},{"key":"10739_CR83","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.7150\/thno.22958","volume":"8","author":"CY Chen","year":"2018","unstructured":"Chen, C. Y., Rao, S. S., Ren, L., et al. (2018). Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics, 8, 1607\u20131623.","journal-title":"Theranostics"},{"key":"10739_CR84","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/HYPERTENSIONAHA.113.02647","volume":"63","author":"P Xu","year":"2014","unstructured":"Xu, P., Zhao, Y., Liu, M., et al. (2014). Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension, 63, 1276\u20131284.","journal-title":"Hypertension"},{"key":"10739_CR85","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1373\/clinchem.2007.097972","volume":"54","author":"SSC Chim","year":"2008","unstructured":"Chim, S. S. C., Shing, T. K. F., Hung, E. C. W., et al. (2008). Detection and characterization of placental microRNAs in maternal plasma. Clinical Chemistry, 54, 482\u2013490.","journal-title":"Clinical Chemistry"},{"key":"10739_CR86","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1373\/clinchem.2010.147660","volume":"56","author":"K Miura","year":"2010","unstructured":"Miura, K., Miura, S., Yamasaki, K., et al. (2010). Identification of pregnancy-associated microRNAs in maternal plasma. Clinical Chemistry, 56, 1767\u20131771.","journal-title":"Clinical Chemistry"},{"key":"10739_CR87","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1095\/biolreprod.108.075481","volume":"81","author":"SS Luo","year":"2009","unstructured":"Luo, S. S., Ishibashi, O., Ishikawa, G., et al. (2009). Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biology of Reproduction, 81, 717\u2013729.","journal-title":"Biology of Reproduction"},{"key":"10739_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-22070-w","volume":"8","author":"J M\u00fcller-Deile","year":"2018","unstructured":"M\u00fcller-Deile, J., Schr\u00f6der, P., Beverly-Staggs, L., et al. (2018). Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish. Scientific Reports, 8, 1\u201315.","journal-title":"Scientific Reports"},{"key":"10739_CR89","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.biopha.2017.07.130","volume":"94","author":"J Xiao","year":"2017","unstructured":"Xiao, J., Tao, T., Yin, Y., et al. (2017). miR-144 may regulate the proliferation, migration and invasion of trophoblastic cells through targeting PTEN in preeclampsia. Biomedicine & Pharmacotherapy, 94, 341\u2013353.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10739_CR90","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/jog.12749","volume":"41","author":"K Miura","year":"2015","unstructured":"Miura, K., Higashijima, A., Murakami, Y., et al. (2015). Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia. The Journal of Obstetrics and Gynaecology Research, 41, 1526\u20131532.","journal-title":"The Journal of Obstetrics and Gynaecology Research"},{"key":"10739_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-023-04240-1","volume":"21","author":"J Zhou","year":"2023","unstructured":"Zhou, J., Zhao, Y., An, P., et al. (2023). Hsa_circ_0002348 regulates trophoblast proliferation and apoptosis through miR-126-3p\/BAK1 axis in preeclampsia. J Transl Med, 21, 1\u201318.","journal-title":"J Transl Med"},{"key":"10739_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-023-04371-5","volume":"22","author":"J Yang","year":"2024","unstructured":"Yang, J., Li, L., Wang, L., et al. (2024). Trophoblast-derived mir-410-5p induces M2 macrophage polarization and mediates immunotolerance at the fetal-maternal interface by targeting the STAT1 signaling pathway. J Transl Med, 22, 1\u201327.","journal-title":"J Transl Med"},{"key":"10739_CR93","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/jcmm.13985","volume":"23","author":"N Wang","year":"2019","unstructured":"Wang, N., Li, R., & Xue, M. (2019). Potential regulatory network in the PSG10P\/miR-19a-3p\/IL1RAP pathway is possibly involved in preeclampsia pathogenesis. Journal of Cellular and Molecular Medicine, 23, 852\u2013864.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10739_CR94","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/humc.2015.2518","volume":"26","author":"D Gancberg","year":"2015","unstructured":"Gancberg, D., Hoeveler, A., Draghia-Akli, R., & Introduction (2015). Gene therapy and gene transfer projects of the 7th Framework Programme for Research and Technological Development of the European Union (Second Part). Hum Gene Ther Clin Dev, 26, 77.","journal-title":"Hum Gene Ther Clin Dev"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10739-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-024-10739-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10739-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T11:57:49Z","timestamp":1723463869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-024-10739-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10739"],"URL":"https:\/\/doi.org\/10.1007\/s12015-024-10739-x","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"17 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}